News

Bristol Myers’ Top Doctor Exits in Midst of Search for New Hit Drug
Bristol-Myers Squibb Co.’s chief medical officer is stepping down from his role after six years at the company, a surprise ...
Zacks Investment Research on MSN23h
Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?
Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...
Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices — Update
Pharmaceutical companies have been in talks with the U.S. government to figure out how to bring drug prices down after President Trump signed in May an executive order that ties U.S. prices to the ...
Fierce Pharma22h
Roche CEO weighs direct-to-consumer drug sales to ease US drug pricing woes, cut out middlemen
A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.
Bristol Myers Squibb taps Cristian Massacesi as CMO
Bristol Myers Squibb appoints Cristian Massacesi as EVP, Chief Medical Officer, & Head of Development starting Aug 2025.